/
6810.TWO
No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Bio Preventive Medicine Corp.
Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical development phase, specializes in the proactive identification and mitigation of various illnesses. The company develops comprehensive strategies for the prevention, screening, and ongoing oversight of chronic conditions and cancer treatment. A key offering is the DNlite test, a suite of proprietary and medically validated non-intrusive urine analyses designed to aid in the management of diabetic kidney disease, encompassing specific products like DNlite-IVD103 and DNlite-DN_Score. Established in 2014, its main operations are located in Zhubei, Taiwan.
www.bpmbiotech.com- Employees
- 26
- IPO / List date
- Aug 30, 2021
- HQ
- TW
Held by traders on TradeandTell
No one on the platform currently holds 6810.TWO.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in 6810.TWO as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded 6810.TWO yet.